GS
QNTM

GTS Securities’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

GTS Securities’s Portfolio QNTM Stock Details QNTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,300
Closed -$89.8K – 1902
2025
Q4 		$89.8K Buy
+12,300
New +$134K ﹤0.01% 1316

Other funds holding QNTM

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PTP
Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

GTS Securities's QNTM Position: Q1 2026 in Review

GTS Securities sold out of Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q1 2026, closing a stake of 12,300 shares — an estimated $89.8K sold.

GTS Securities first reported a position in QNTM in Q4 2025 and held it in 1 quarter. The position peaked at $89.8K in Q4 2025. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

  • GTS Securities reported no remaining Quantum Biopharma Class B Subordinate Voting Shares position as of Q1 2026 after selling out during the quarter.
  • GTS Securities sold 12,300 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2026, an estimated $89.8K.
  • GTS Securities first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q4 2025 and held it in 1 quarter.
  • GTS Securities's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $89.8K in Q4 2025.
  • 25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.